title: Vancomycin-resistant enterococcus (VRE) transmission and risk factors in contacts of VRE carriers.
abstract: During a 2-year period, the vancomycin-resistant enterococcus (VRE) acquisition rate was 10.9% (40/368) in patients who had shared a room with a newly detected VRE carrier. Exposure to vancomycin and to anti-anaerobic antibiotics were identified as independent risk factors for VRE acquisition. Sensitivity of the first rectal VRE screening was less than 50%.
authors.affiliation: Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
authors.forename: Reham
authors.initials: R
authors.lastname: Kaki
authors.forename: Yang
authors.initials: Y
authors.lastname: Yu
authors.forename: Cindy
authors.initials: C
authors.lastname: O'Neill
authors.forename: Christine
authors.initials: C
authors.lastname: Lee
authors.forename: Dominik
authors.initials: D
authors.lastname: Mertz
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State; D003428:Cross Infection / Q000517:prevention & control*; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D016908:Gram-Positive Bacterial Infections / Q000635:transmission*; D006801:Humans; D017053:Infection Control; D009864:Ontario; D012007:Rectum / Q000382:microbiology; D012307:Risk Factors; D062606:Tertiary Care Centers; D065507:Vancomycin-Resistant Enterococci / Q000302:isolation & purification*
chemical_list: D000900:Anti-Bacterial Agents